Skip to Content

Gates Foundation to Invest Up to $140 Million in HIV Prevention Device

THE WALL STREET JOURNAL

Intarcia Therapeutics is developing implantable pump which holds six or 12 months’ supply of medicine

Shaping the future:

Press Releases

Intarcia Appoints Thane Wettig as Chief Marketing Officer and Metabolic Franchise Head

Read More

Intarcia Provides Corporate Update

Read More

Intarcia Strengthens Board of Directors for Next Stage of Growth

Read More
MORE NEWS
Back to top